Company context

Gilead Sciences, Inc.

NASDAQ:GILD

Biotechnology · benchmarked against Biotechnology inside the XLV constituent company universe.

Active tabPeers

Current readGood

Last close130.48

1M return+0.67%

OverviewVerdict, thesis map, and valuation setup.FundamentalsDrivers, trajectory, and business quality.Financial reportsStatement tables, sorting, filtering, and acceleration.Ex-ante forecastTarget price, dividend yield, and total return by horizon.FactorsCompany factor exposure, rank, and universe context.Market viewMomentum, catalysts, charts, and symbol packet.AttributionLarge-move causes, residuals, and research backlog.OwnershipSEC 13F holder flow, crowding, and manager changes.PeersPeer heatmap and closest comparables.

Tab scope

Relative comparables

Peers

Source and lookbackPeer fundamentals and stored return summaries5100 stored daily bars; peer return rows use each peer's stored price summary where available.

Sample and caveat12 closest comparables from industry, sector, and market peer pools.Use this tab for its stated job; heavier model packets stay on their own tabs.

Peer return matrix

Cumulative returns across peer horizons

Stored daily closes, when available

NASDAQ:GILD 1W -4.27%, 1M +0.67%, 3M +0.62%, 6M -11.74%, 1Y +15.50%, 3Y +69.76%; NASDAQ:AMGN 1W -1.65%, 1M -0.27%, 3M +12.66%, 6M -3.06%, 1Y +27.02%, 3Y +42.54%; NYSE:IQV 1W -4.30%, 1M -2.20%, 3M +16.57%, 6M +15.80%, 1Y +5.57%, 3Y -8.02%; NASDAQ:MRNA 1W -5.87%, 1M -27.33%, 3M +30.01%, 6M +19.29%, 1Y +146.74%, 3Y -46.90%; NASDAQ:TECH 1W +0.72%, 1M +23.82%, 3M +40.92%, 6M +9.56%, 1Y +42.28%, 3Y -12.69%; NYSE:BSX 1W -3.38%, 1M -3.34%, 3M -22.91%, 6M -41.62%, 1Y -59.14%, 3Y -15.07%; NASDAQ:REGN 1W -0.61%, 1M +3.84%, 3M +7.16%, 6M -11.98%, 1Y +16.20%, 3Y -18.74%; NYSE:BMY 1W +0.55%, 1M +7.30%, 3M +6.16%, 6M -0.62%, 1Y +28.95%, 3Y -2.00%; NYSE:JNJ 1W -0.08%, 1M -3.69%, 3M +9.10%, 6M +1.22%, 1Y +40.97%, 3Y +50.23%; NYSE:MDT 1W -1.61%, 1M -1.02%, 3M +6.33%, 6M -14.99%, 1Y -11.42%, 3Y +0.03%; NYSE:SYK 1W -4.73%, 1M -2.84%, 3M +0.73%, 6M -17.96%, 1Y -19.39%, 3Y +13.45%

Company1W1M

3M

6M

1Y

3Y

NASDAQ:GILD-4.27%+0.67%+0.62%-11.74%+15.50%+69.76%

NASDAQ:AMGN-1.65%-0.27%+12.66%-3.06%+27.02%+42.54%

NYSE:IQV-4.30%-2.20%+16.57%+15.80%+5.57%-8.02%

NASDAQ:MRNA-5.87%-27.33%+30.01%+19.29%+146.74%-46.90%

NASDAQ:TECH+0.72%+23.82%+40.92%+9.56%+42.28%-12.69%

NYSE:BSX-3.38%-3.34%-22.91%-41.62%-59.14%-15.07%

NASDAQ:REGN-0.61%+3.84%+7.16%-11.98%+16.20%-18.74%

NYSE:BMY+0.55%+7.30%+6.16%-0.62%+28.95%-2.00%

NYSE:JNJ-0.08%-3.69%+9.10%+1.22%+40.97%+50.23%

NYSE:MDT-1.61%-1.02%+6.33%-14.99%-11.42%+0.03%

NYSE:SYK-4.73%-2.84%+0.73%-17.96%-19.39%+13.45%

Peer scorecard analytics

Different ways to compare this peer set

11 companies including target

Return leadership

NASDAQ:MRNA+146.74% 1Y · -46.90% 3Y

NASDAQ:TECH+42.28% 1Y · -12.69% 3Y

NYSE:JNJ+40.97% 1Y · +50.23% 3Y

NYSE:BMY+28.95% 1Y · -2.00% 3Y

Risk and quality spread

NASDAQ:AMGNGM +71.51% · ROE +101.32%

NYSE:JNJGM +75.08% · ROE n/a

NASDAQ:GILDGM +79.41% · ROE +43.19%

NYSE:BMYGM +66.07% · ROE +38.84%

Valuation screen

NASDAQ:REGNP/E 16.38 · FCF yield +5.84%

NYSE:BMYP/E 16.89 · FCF yield +9.69%

NASDAQ:GILDP/E 18.13 · FCF yield +6.19%

NYSE:BSXP/E 18.35 · FCF yield +5.34%

Valuation versus growth

P/E against 1Y return

NASDAQ:GILD P/E 18.13 1Y +15.50%, NASDAQ:AMGN P/E 25.33 1Y +27.02%, NYSE:IQV P/E 25.27 1Y +5.57%, NASDAQ:MRNA P/E n/a 1Y +146.74%, NASDAQ:TECH P/E 102.90 1Y +42.28%, NYSE:BSX P/E 18.35 1Y -59.14%, NASDAQ:REGN P/E 16.38 1Y +16.20%, NYSE:BMY P/E 16.89 1Y +28.95%, NYSE:JNJ P/E 28.84 1Y +40.97%, NYSE:MDT P/E 22.35 1Y -11.42%, NYSE:SYK P/E 36.97 1Y -19.39%

Peer heatmap

Where this company wins and lags

12 stored peers

CompanyP/E TTMPrice / SalesFCF yieldGross marginReturn on equityDebt / Equity

NASDAQ:GILDGilead Sciences, Inc.

18.13100th pctile5.6560th pctile+6.19%80th pctile+79.41%100th pctile+43.19%80th pctile0.9460th pctile

NASDAQ:AMGNAmgen Inc.

25.3317th pctile5.3443rd pctile+4.37%29th pctile+71.51%71st pctile+101.32%100th pctile6.240th pctile

NYSE:IQVIQVIA Holdings, Inc.

25.2733rd pctile2.11100th pctile+6.22%86th pctile+25.97%14th pctile+22.71%57th pctile2.5814th pctile

NASDAQ:MRNAModerna, Inc.

n/an/a10.970th pctile-6.79%0th pctile+11.55%0th pctile-36.56%0th pctile0.1871st pctile

NASDAQ:TECHBio-Techne Corp

102.900th pctile9.3814th pctile+2.40%14th pctile+66.40%57th pctile+5.34%14th pctile0.1486th pctile

NYSE:BSXBoston Scientific Corporation

18.3550th pctile3.1971st pctile+5.34%43rd pctile+65.44%29th pctile+14.83%43rd pctile0.4357th pctile

NASDAQ:REGNRegeneron Pharmaceuticals, Inc.

16.38100th pctile4.8857th pctile+5.84%57th pctile+80.93%100th pctile+14.55%29th pctile0.09100th pctile

NYSE:BMYBristol-Myers Squibb Company

16.8983rd pctile2.5686th pctile+9.69%100th pctile+66.07%43rd pctile+38.84%71st pctile2.3129th pctile

Color ranks each metric in the favorable direction, so lower leverage and cheaper multiples can still score green.